vimarsana.com
Home
Live Updates
Connect Biopharma to Present a Late-Breaking Abstract at the
Connect Biopharma to Present a Late-Breaking Abstract at the
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
SAN DIEGO, CA and TAICANG, China, May 07, 2024 -- Connect Biopharma Holdings Limited , a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic...
Related Keywords
San Diego ,
California ,
United States ,
China ,
San Diego Convention Center ,
Taicang ,
Hebei ,
Tim Mccarthy ,
Edward Kerwin ,
Biopharma Holdings ,
International Meeting ,
Airway Inflammation ,
Biopharma Holdings Limited Nasdaq ,
International Conference ,
Biopharma Holdings Limited ,
Improved Lung Function ,
Asthma Control Observed ,
Moderate To Severe Uncontrolled Asthma ,
Immune Response ,
Upper Level ,
Markets ,